Cellectar Biosciences Inc (CLRB)
3.02
-0.04
(-1.31%)
USD |
NASDAQ |
Apr 25, 16:00
3.015
0.00 (0.00%)
After-Hours: 20:00
Cellectar Biosciences Total Liabilities (Quarterly): 13.43M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.43M |
| September 30, 2023 | 34.90M |
| June 30, 2023 | 6.976M |
| March 31, 2023 | 7.504M |
| December 31, 2022 | 6.082M |
| September 30, 2022 | 6.569M |
| June 30, 2022 | 5.698M |
| March 31, 2022 | 4.781M |
| December 31, 2021 | 4.157M |
| September 30, 2021 | 3.368M |
| June 30, 2021 | 3.755M |
| March 31, 2021 | 5.289M |
| December 31, 2020 | 3.865M |
| September 30, 2020 | 4.473M |
| June 30, 2020 | 3.867M |
| March 31, 2020 | 3.444M |
| December 31, 2019 | 3.191M |
| September 30, 2019 | 3.428M |
| June 30, 2019 | 3.150M |
| March 31, 2019 | 2.702M |
| December 31, 2018 | 1.793M |
| September 30, 2018 | 2.661M |
| June 30, 2018 | 2.290M |
| March 31, 2018 | 2.109M |
| December 31, 2017 | 2.117M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.279M |
| June 30, 2017 | 1.737M |
| March 31, 2017 | 1.548M |
| December 31, 2016 | 1.785M |
| September 30, 2016 | 1.579M |
| June 30, 2016 | 1.549M |
| March 31, 2016 | 2.993M |
| December 31, 2015 | 5.947M |
| September 30, 2015 | 5.781M |
| June 30, 2015 | 6.207M |
| March 31, 2015 | 6.323M |
| December 31, 2014 | 6.722M |
| September 30, 2014 | 2.570M |
| June 30, 2014 | 8.429M |
| March 31, 2014 | 8.767M |
| December 31, 2013 | 5.116M |
| September 30, 2013 | 5.221M |
| June 30, 2013 | 6.681M |
| March 31, 2013 | 7.181M |
| December 31, 2012 | 1.320M |
| September 30, 2012 | 1.322M |
| June 30, 2012 | 1.219M |
| March 31, 2012 | 1.087M |
| December 31, 2011 | 1.082M |
| September 30, 2011 | 1.098M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.150M
Minimum
Jun 2019
34.90M
Maximum
Sep 2023
6.733M
Average
4.473M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 22.71M |
| Eli Lilly and Co | 53.14B |
| Actinium Pharmaceuticals Inc | 45.07M |
| Bristol-Myers Squibb Co | 65.67B |
| Altimmune Inc | 16.54M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.08M |
| Shareholders Equity (Quarterly) | -1.356M |